Asabys Partners, CataloniaBio & HealthTech member, and Alantra have reached a strategic partnership agreement, where Alantra will acquire a 35% stake in the venture capital firm specialized in investments in the life sciences and health sectors.
Alantra will also invest in the first fund of the firm (Sabadell Asabys Health Innovation Investments) and will support the company in its search for new investors to increase the fund size to over 80 million euros.
This transaction represents Alantra’s first venture capital deal led by Ana Segurado, managing partner of Alantra for VC projects, and former executive of Telefonica.
Photo: From left to right, Josep Lluís Sanfeliu (Asabys), Ana Segurado (Alantra) and Clara Campàs (Asabys) - © Alantra
We recommend the videointerview by CataloniaBioHT:
Comments